Issues of Vaccination During COVID

  • Issue of patent vs public health
  • India does not have enough production capacities which led to rise of second wave
  • Compulsory licensing,even if its issued there is no necessary capability to develop same vaccine by other companies
  • Data exclusivity: Even if vaccine waiver is provided but it does not lead to provision of research related information which can delay production of vaccine
  • Reduces private investment and innovation in future in case of Vaccine waiver
  • Lack of uniform vaccine pricing across all states causing Federal disputes
  • Issue of vaccine hesitancy
  • Vaccine diplomacy and scarcity of vaccines in India

 

Suggestions:

India should increase its production capabilities

Global pooling of resources and compensation of private players for innovation and improve vaccine availability to all nation